Bg pattern

DOLOTREN 46.5 mg dispersible tablets

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use DOLOTREN 46.5 mg dispersible tablets

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

Dolotren 46.5 mg Dispersible Tablets

diclofenac

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.,as it contains important information for you..

  • Keep this leaflet, as you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the Package Leaflet

  1. What is Dolotren and what is it used for
  2. What you need to know before you take Dolotren
  3. How to take Dolotren
  4. Possible side effects
  5. Storage of Dolotren
  6. Contents of the pack and other information

1. What is Dolotren and what is it used for

The active substance of Dolotren 46.5 mg dispersible tablets is diclofenac (equivalent to 50 mg of diclofenac sodium).

Dolotren belongs to a group of medicines called non-steroidal anti-inflammatory drugs, used to treat pain and inflammation.

Dolotren is used for the short-term treatment of acute inflammatory and painful conditions after trauma and surgery.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you take Dolotren

It is important that you use the smallest dose of Dolotren that relieves or controls your pain and you should not take this medicine for longer than necessary to control your symptoms.

Do not take Dolotren

  • if you are allergic (hypersensitive) to diclofenac or any of the other ingredients of this medicine (listed in section 6).
  • if you are allergic or have had allergic reactions to acetylsalicylic acid (aspirin) or other similar painkillers. Reactions can include asthma (difficulty breathing), hives (allergic reaction on the skin with itching), acute rhinitis (inflammation of the nasal mucosa) or swelling of the face. If you think you may be allergic, consult your doctor.
  • if you have had a stomach or duodenal hemorrhage, or have suffered a perforation of the digestive tract while taking a non-steroidal anti-inflammatory medicine.
  • if you currently have or have had more than once: a stomach or duodenal ulcer or hemorrhage.
  • if you have active Crohn's disease or ulcerative colitis (diseases that produce diarrhea with or without blood and abdominal pain).
  • if you have severe kidney disease.
  • if you have severe liver disease.
  • if you have established heart disease and/or cerebrovascular disease, for example, if you have had a heart attack, stroke, mini-stroke (TIA) or blockages in the blood vessels of the heart or brain, or have had surgery to remove a blockage or perform a coronary bypass.
  • if you have had problems with blood circulation (peripheral arterial disease).
  • if you are in the third trimester of pregnancy.
  • if you have blood coagulation disorders.

Make sure your doctor knows before taking diclofenac:

  • if you smoke
  • if you have diabetes
  • if you have angina, blood clots, high blood pressure, high cholesterol, or high triglycerides.

Side effects can be minimized by using the lowest effective dose for the shortest possible time.

Warnings and Precautions

Consult your doctor or pharmacist before starting to take Dolotren

  • if you have had or developed an ulcer, hemorrhage, or perforation in the stomach or duodenum, which may be manifested by severe or persistent abdominal pain and/or black stools, or even without previous warning symptoms.

This risk is greater when high doses and prolonged treatments are used, in patients with a history of peptic ulcer and in the elderly. In these cases, your doctor will consider the possibility of associating a stomach protective medicine.

  • if you have any of the following conditions: asthma, mild heart disease, liver or kidney disease, high blood pressure (hypertension), bleeding disorders, or other blood disorders, including hepatic porphyria.
  • if you are taking other anti-inflammatory medicines, including acetylsalicylic acid/aspirin, corticosteroids, anticoagulants, or antidepressants, as this increases the risk of ulcers and/or gastrointestinal bleeding (see the section "Other medicines and Dolotren").
  • if you are taking medicines for blood pressure or cyclosporine, as this increases the risk of kidney damage (see the section "Other medicines and Dolotren").
  • Some people SHOULD NOT use Dolotren. Consult your doctor if you think you may be allergic to diclofenac sodium, acetylsalicylic acid, ibuprofen, or any other ingredient of Dolotren. (These are listed at the end of the leaflet). The signs of a hypersensitivity reaction are swelling of the face and mouth (angioedema), breathing problems, chest pain, runny nose, skin rash, or any other allergic reaction.
  • If you have ever had a severe skin rash or peeling of the skin, blisters, or sores in the mouth after taking Dolotren or other painkillers.

Tell your doctor

  • if you are taking medicines that affect blood clotting or increase the risk of ulcers, such as oral anticoagulants or antiplatelet agents of the acetylsalicylic acid type. You should also discuss the use of other medicines that may increase the risk of such bleeding, such as corticosteroids and selective serotonin reuptake inhibitor antidepressants.
  • if you have Crohn's disease or ulcerative colitis, as medicines like Dolotren may worsen these conditions.
  • if you have high blood pressure, high cholesterol, or high triglycerides, diabetes, or are a smoker (cardiovascular risk factors), your doctor should regularly reassess whether you should continue treatment with Dolotren, especially if you have been treated for more than 4 weeks.
  • if you have liver or kidney failure, or blood disorders, you will need to have frequent blood tests during your treatment. This will allow your doctor to monitor the functioning of your liver (transaminase levels) or kidneys (creatinine levels) or blood (lymphocyte, erythrocyte, and platelet levels). With this, your doctor can decide to interrupt or change the dose of Dolotren.
  • if you have recently undergone or are going to undergo stomach or intestinal surgery before taking Dolotren, as Dolotren may sometimes worsen the healing of intestinal wounds after surgery.

Patients with cardiovascular problems

Medicines like Dolotren may be associated with an increased risk of heart attacks (myocardial infarction) or strokes, especially when used in high doses and for prolonged periods. Do not exceed the recommended dose or duration of treatment.

If you have heart problems, a history of strokes, or think you may be at risk of having them (for example, you have high blood pressure, diabetes, high cholesterol, or triglycerides, or are a smoker) and your doctor decides to treat you with this medicine, you should not take more than 100 mg per day if the treatment lasts more than 4 weeks.

Also, this type of medicine may cause fluid retention, especially in patients with heart disease and/or high blood pressure (hypertension).

In general, it is very important to take the lowest effective dose of Dolotren for the shortest possible time that relieves pain and/or inflammation to reduce the risk of cardiovascular side effects.

If you experience chest pain, shortness of breath, weakness, or difficulty speaking while taking this medicine, contact your doctor immediately.

Children and Adolescents

The use of this medicine is not recommended in children and adolescents under 14 years of age.

Use in Elderly Patients

Elderly patients may be more sensitive to the effects of this medicine than other adults. Therefore, it is especially important that elderly patients inform their doctor immediately of any side effects.

Other Medicines and Dolotren

Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines, including those obtained without a prescription.

Certain medicines may interfere with Dolotren, and in these cases, it may be necessary to change the dose or interrupt treatment with one of them.

It is important that you inform your doctor if you are taking or have recently taken any of the following medicines:

  • medicines containing lithium or selective serotonin reuptake inhibitors (for treating some types of depression),
    • medicines containing methotrexate (for treating cancer and rheumatoid arthritis),
    • medicines containing cyclosporine, tacrolimus (after transplants),
    • medicines containing trimethoprim (for preventing and treating urinary tract diseases),
    • medicines for treating heart problems (digoxin, calcium antagonists such as verapamil or isradipine),
    • medicines used to treat diabetes, except insulin,
    • medicines for controlling blood pressure (diuretics, beta-blockers, and ACE inhibitors),
    • medicines for preventing blood clots,
    • medicines containing quinolone or ceftriaxone (for treating infections),
    • other medicines of the same group as diclofenac (non-steroidal anti-inflammatory drugs), such as acetylsalicylic acid or ibuprofen,
    • corticosteroids (medicines that reduce inflammation and the action of the immune system),
    • medicines containing voriconazole (a medicine used in the treatment of fungal infections),
    • medicines containing phenytoin (a medicine used to treat epileptic seizures),
    • medicines containing misoprostol (for treating stomach ulcers),
    • medicines containing cholestyramine and colestipol (for reducing cholesterol levels in the blood),
    • medicines containing pentazocine (for relieving pain).

Taking Dolotren with Food and Alcohol

This medicine should be taken preferably before meals or on an empty stomach, as food reduces absorption.

Consuming alcoholic beverages with Dolotren may increase its toxicity.

Pregnancy, Breastfeeding, and Fertility

If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Pregnancy

Because the administration of medicines like Dolotren has been associated with an increased risk of congenital anomalies/abortions, it is not recommended to take this medicine during the first and second trimester of pregnancy unless it is strictly necessary and as indicated by your doctor. If treatment is needed during this period or while trying to become pregnant, you should take the minimum dose for the shortest possible time.

From the 20th week of pregnancy, Dolotren may cause kidney problems in your fetus if taken for more than a few days, which can lead to low levels of amniotic fluid surrounding the baby (oligohydramnios). If you need treatment for more than a few days, your doctor may recommend additional checks.

In the third trimester, the administration of Dolotren is contraindicated as it may harm your fetus or cause problems during delivery. It may cause kidney and heart problems in your fetus. It may affect your and your baby's tendency to bleed and delay or prolong delivery more than expected.

Breastfeeding

Small amounts of Dolotren may appear in breast milk, so you should not take this medicine if you are breastfeeding.

Fertility

For women of childbearing age, it should be noted that medicines like Dolotren have been associated with a decrease in fertility.

Driving and Using Machines

The influence of diclofenac on the ability to drive and use machines is negligible or minimal. However, patients who experience visual disturbances, dizziness, vertigo, drowsiness, or other central nervous system disorders while taking Dolotren should avoid driving vehicles or operating machinery.

Dolotren 46.5 mg Dispersible Tablets contain sodium (from potato starch carboxymethylamide, sodium stearyl fumarate, and sodium saccharin)

This medicine contains less than 23 mg of sodium (1 mmol) per dispersible tablet; this is, essentially "sodium-free"

3. How to Take Dolotren

Follow exactly the administration instructions of this medicine given by your doctor or pharmacist. If you are unsure, consult your doctor or pharmacist again.

Use in Adults and Children over 14 years

In milder cases, 2 Dolotren tablets per day are usually sufficient. Do not exceed the dose of 3 tablets (150 mg of diclofenac) per day. The total daily dose should be divided into 2 or 3 divided doses.

Method of Administration

This medicine should be taken preferably before meals or on an empty stomach (see the section "Taking Dolotren with Food and Beverages").

The tablets should be dissolved in a glass of water. Put one tablet in a glass of water and stir. Once dissolved, drink the liquid. If there are any remains in the glass, add more water and repeat the process.

If you take more Dolotren than you should

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service. Telephone: 91 562 04 20, indicating the medicine and the amount taken. It is recommended to take the package and the leaflet of the medicine to the healthcare professional.

If you forget to take Dolotren

Do not take a double dose to make up for forgotten doses.

If you forget a dose, take it as soon as you can, unless it is almost time for the next dose; then return to your regular dosing schedule. If you forget several doses, consult your doctor.

If you have any other questions about the use of this medicine, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible Adverse Effects

Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.

Some adverse effects can be serious.

Stop using Dolotren and inform your doctor immediately if you experience any of the following serious adverse effects; you may need urgent medical treatment:

  • Mild abdominal colic and abdominal pain on palpation that begins shortly after starting treatment with this medicine, followed by rectal bleeding or bloody diarrhea, usually observed within 24 hours after the onset of abdominal pain (frequency not known, cannot be determined from available data).
  • Chest pain, which can be a sign of a potentially serious allergic reaction called Kounis syndrome.
  • Severe allergic skin reaction, which can include large, generalized red or dark spots, skin swelling, blisters, and itching (generalized fixed drug eruption).

Frequent Adverse Effects (occurring in at least 1 in 100 patients)

Nervous System Disorders

  • headache
  • dizziness

Ear and Labyrinth Disorders

  • vertigo

Gastrointestinal Disorders

  • nausea
  • vomiting
  • diarrhea
  • heartburn
  • abdominal pain
  • gas
  • loss of appetite

Hepatobiliary Disorders

  • abnormal liver function test results (elevated serum transaminases)

Skin and Subcutaneous Tissue Disorders

  • skin rash
  • Uncommon Adverse Effects (occurring in at least 1 in 1,000 patients):

    Cardiac Disorders(at high doses during prolonged treatments)

    • palpitations
    • sudden severe chest pain (symptoms of myocardial infarction or heart attack)
    • shortness of breath, difficulty breathing when lying down, swelling of feet and legs (signs of heart failure)

    If these symptoms appear, consult your doctor immediately.

Rare Adverse Effects (occurring in at least 1 in 10,000 patients):

Immune System Disorders

  • swelling of the face, eyes, or tongue, difficulty swallowing, wheezing, hives, and generalized itching, skin rash, fever, abdominal cramps, chest tightness or discomfort, difficulty breathing, dizziness, loss of consciousness (severe allergic reaction).

If these symptoms appear, consult your doctor immediately.

Nervous System Disorders

  • drowsiness

Respiratory, Thoracic, and Mediastinal Disorders

  • asthma

Gastrointestinal Disorders

  • stomach pain
  • reflux
  • bloody diarrhea
  • gastric or intestinal ulcer with or without bleeding or perforation (vomiting blood and appearance of blood in stools). If these symptoms appear, consult your doctor immediately.

Hepatobiliary Disorders

  • liver function disorder
  • hepatitis with or without jaundice. If these symptoms appear, consult your doctor immediately.

Skin and Subcutaneous Tissue Disorders

  • hives

General Disorders and Administration Site Conditions

  • fluid retention, with swelling (edema)

Very Rare Adverse Effects (occurring in less than 1 in 10,000 patients):

Blood and Lymphatic System Disorders

  • signs of lack of blood cells that cause fatigue, headache, shortness of breath when exercising, dizziness, paleness (anemia), frequent infections with fever, chills, sore throat or mouth ulcers (leukopenia), bleeding or bruising more than usual (thrombocytopenia).

If these symptoms appear, consult your doctor immediately.

Immune System Disorders

  • swelling of the face

Psychiatric Disorders

  • disorientation
  • depression
  • insomnia
  • nightmares
  • irritability
  • psychotic reactions

Nervous System Disorders

  • tingling sensation
  • memory disorders
  • seizures
  • anxiety
  • tremor
  • meningitis (inflammation of the membranes surrounding the brain) with symptoms such as fever, nausea, vomiting, headache, neck stiffness or extreme sensitivity to bright light. If these symptoms appear, consult your doctor immediately.
  • taste disorders
  • stroke

Eye Disorders

  • blurred vision
  • double vision

Ear and Labyrinth Disorders

  • ringing in the ears

Vascular Disorders

  • hypertension (high blood pressure)
  • vasculitis (inflammation of blood vessel walls)

Respiratory, Thoracic, and Mediastinal Disorders

  • difficulty breathing, wheezing (pneumonitis). If these symptoms appear, consult your doctor immediately.

Gastrointestinal Disorders

  • worsening of Crohn's disease and ulcerative colitis
  • constipation
  • tongue swelling (glossitis)
  • inflammation of the mouth mucosa (stomatitis)
  • difficulty swallowing (esophageal disorder)
  • severe pain in the upper abdomen, nausea, vomiting, and loss of appetite (signs of pancreatitis). If these symptoms appear, consult your doctor immediately.

Skin and Subcutaneous Tissue Disorders

  • severe skin reactions with rash, redness, blisters on the lips, mouth, or eyes, skin peeling, accompanied by fatigue, nausea, loss of appetite, fever, chills, headache, cough, or body pain (Stevens-Johnson syndrome or toxic epidermal necrolysis). If these symptoms appear, consult your doctor immediately.
  • generalized rash (eczema)
  • redness (erythema and erythema multiforme)
  • skin peeling (exfoliative dermatitis)
  • hair loss
  • sun allergy (photosensitivity reaction)
  • appearance of bruises (purpura)
  • itching

Renal and Urinary Disorders

  • kidney function disorders that cause swelling in feet or legs and sudden decrease in urine output (acute renal failure, interstitial nephritis, renal papillary necrosis)
  • blood in urine (hematuria)
  • foam in urine (nephrotic syndrome)

If these symptoms appear, consult your doctor immediately.

Adverse Effects of Unknown Frequency (cannot be estimated from available data)

Skin and Subcutaneous Tissue Disorders

  • allergic skin reaction, which can include round or oval patches of redness and skin swelling, blisters, and itching (fixed drug eruption). It can also cause darkening of the skin in the affected areas, which may persist after healing. Fixed drug eruption usually recurs in the same or different areas if the medicine is taken again.

Hepatobiliary Disorders

  • liver function disorders that cause yellowing of the skin and eyes, fever, with pain in the upper abdomen and bruising (liver failure, fulminant hepatitis, liver necrosis)

If these symptoms appear, consult your doctor immediately.

Reporting of Adverse Effects:

If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect not listed in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es/. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.

5. Storage of Dolotren

Keep this medicine out of sight and reach of children.

Store the blister pack in the outer packaging to protect it from moisture.

Do not use Dolotren after the expiration date indicated on the box after CAD. The expiration date is the last day of the month indicated.

Medicines should not be thrown away through wastewater or household waste. Deposit the packaging and medicines you no longer need at the SIGRE collection point in your pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This way, you will help protect the environment.

6. Package Contents and Additional Information

Dolotren Composition

  • The active ingredient is diclofenac. Each tablet contains 46.5 mg of diclofenac (equivalent to 50 mg of diclofenac sodium).
  • The other ingredients (excipients) are: microcrystalline cellulose, corn starch, sodium starch glycolate, crospovidone, orange flavor, polyethylene glycol 6000, sodium stearyl fumarate, sodium saccharin, anhydrous colloidal silica.

Product Appearance and Package Contents

Each package contains 40 dispersible tablets, white in color.

Marketing Authorization Holder

Faes Farma, S.A.

Autonomia Etorbidea, 10

48940 Leioa (Bizkaia)

Spain

Manufacturer

Faes Farma, S.A.

Maximo Agirre Kalea, 14

48940 Leioa (Bizkaia)

Spain

O

Faes Farma, S.A.

Parque Científico y Tecnológico de Bizkaia

Ibaizabal Bidea, Edificio 901

48160 Derio (Bizkaia)

Spain

Date of Last Revision of this Prospectus:July 2025

Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

Online doctors for DOLOTREN 46.5 mg dispersible tablets

Discuss questions about DOLOTREN 46.5 mg dispersible tablets, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for DOLOTREN 46.5 mg dispersible tablets?
DOLOTREN 46.5 mg dispersible tablets requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in DOLOTREN 46.5 mg dispersible tablets?
The active ingredient in DOLOTREN 46.5 mg dispersible tablets is diclofenac. This information helps identify medicines with the same composition but different brand names.
How much does DOLOTREN 46.5 mg dispersible tablets cost in pharmacies?
The average pharmacy price for DOLOTREN 46.5 mg dispersible tablets is around 1.65 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures DOLOTREN 46.5 mg dispersible tablets?
DOLOTREN 46.5 mg dispersible tablets is manufactured by Faes Farma S.A.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of DOLOTREN 46.5 mg dispersible tablets online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether DOLOTREN 46.5 mg dispersible tablets is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to DOLOTREN 46.5 mg dispersible tablets?
Other medicines with the same active substance (diclofenac) include AKIS 25 mg Injectable Solution in Pre-filled Syringe, AKIS 50 mg Injectable Solution in Pre-filled Syringe, AKIS 75 mg Injectable Solution in Pre-filled Syringe. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media